123 related articles for article (PubMed ID: 10806389)
1. Flexibility and stability of the structure of cytochromes P450 3A4 and BM-3.
Anzenbacherová E; Bec N; Anzenbacher P; Hudecek J; Soucek P; Jung C; Munro AW; Lange R
Eur J Biochem; 2000 May; 267(10):2916-20. PubMed ID: 10806389
[TBL] [Abstract][Full Text] [Related]
2. Differences in flexibility of active sites of cytochromes P450 probed by resonance Raman and UV-Vis absorption spectroscopy.
Anzenbacher P; Hudecek J
J Inorg Biochem; 2001 Dec; 87(4):209-13. PubMed ID: 11744058
[TBL] [Abstract][Full Text] [Related]
3. Catalytically self-sufficient P450 CYP102 (cytochrome P450 BM-3): resonance Raman spectral characterization of the heme domain and of the holoenzyme.
Hudeèek J; Baumruk V; Anzenbacher P; Munro AW
Biochem Biophys Res Commun; 1998 Feb; 243(3):811-5. PubMed ID: 9500975
[TBL] [Abstract][Full Text] [Related]
4. Resonance Raman investigations of Escherichia coli-expressed Pseudomonas putida cytochrome P450 and P420.
Wells AV; Li P; Champion PM; Martinis SA; Sligar SG
Biochemistry; 1992 May; 31(18):4384-93. PubMed ID: 1581294
[TBL] [Abstract][Full Text] [Related]
5. Molecular modelling of CYP3A4 from an alignment with CYP102: identification of key interactions between putative active site residues and CYP3A-specific chemicals.
Lewis DF; Eddershaw PJ; Goldfarb PS; Tarbit MH
Xenobiotica; 1996 Oct; 26(10):1067-86. PubMed ID: 8905920
[TBL] [Abstract][Full Text] [Related]
6. Structural similarities and differences of the heme pockets of various P450 isoforms as revealed by resonance Raman spectroscopy.
Hudecek J; Anzenbacherová E; Anzenbacher P; Munro AW; Hildebrandt P
Arch Biochem Biophys; 2000 Nov; 383(1):70-8. PubMed ID: 11097178
[TBL] [Abstract][Full Text] [Related]
7. Dynamics of protein-bound water in the heme domain of P450BM3 studied by high-pressure spectroscopy: comparison with P450cam and P450 2B4.
Davydov DR; Hui Bon Hoa G; Peterson JA
Biochemistry; 1999 Jan; 38(2):751-61. PubMed ID: 9888815
[TBL] [Abstract][Full Text] [Related]
8. Spectral properties of the oxyferrous complex of the heme domain of cytochrome P450 BM-3 (CYP102).
Bec N; Anzenbacher P; Anzenbacherová E; Gorren AC; Munro AW; Lange R
Biochem Biophys Res Commun; 1999 Dec; 266(1):187-9. PubMed ID: 10581187
[TBL] [Abstract][Full Text] [Related]
9. Phenylalanine 393 exerts thermodynamic control over the heme of flavocytochrome P450 BM3.
Ost TW; Miles CS; Munro AW; Murdoch J; Reid GA; Chapman SK
Biochemistry; 2001 Nov; 40(45):13421-9. PubMed ID: 11695888
[TBL] [Abstract][Full Text] [Related]
10. Active sites of two orthologous cytochromes P450 2E1: differences revealed by spectroscopic methods.
Anzenbacherova E; Hudecek J; Murgida D; Hildebrandt P; Marchal S; Lange R; Anzenbacher P
Biochem Biophys Res Commun; 2005 Dec; 338(1):477-82. PubMed ID: 16129410
[TBL] [Abstract][Full Text] [Related]
11. Conformational heterogeneity of cytochrome P450 3A4 revealed by high pressure spectroscopy.
Davydov DR; Halpert JR; Renaud JP; Hui Bon Hoa G
Biochem Biophys Res Commun; 2003 Dec; 312(1):121-30. PubMed ID: 14630029
[TBL] [Abstract][Full Text] [Related]
12. Expression, purification, and characterization of Bacillus subtilis cytochromes P450 CYP102A2 and CYP102A3: flavocytochrome homologues of P450 BM3 from Bacillus megaterium.
Gustafsson MC; Roitel O; Marshall KR; Noble MA; Chapman SK; Pessegueiro A; Fulco AJ; Cheesman MR; von Wachenfeldt C; Munro AW
Biochemistry; 2004 May; 43(18):5474-87. PubMed ID: 15122913
[TBL] [Abstract][Full Text] [Related]
13. Engineered alkane-hydroxylating cytochrome P450(BM3) exhibiting nativelike catalytic properties.
Fasan R; Chen MM; Crook NC; Arnold FH
Angew Chem Int Ed Engl; 2007; 46(44):8414-8. PubMed ID: 17886313
[No Abstract] [Full Text] [Related]
14. NMR studies of substrate binding to cytochrome P450 BM3: comparisons to cytochrome P450 cam.
Modi S; Primrose WU; Boyle JM; Gibson CF; Lian LY; Roberts GC
Biochemistry; 1995 Jul; 34(28):8982-8. PubMed ID: 7619797
[TBL] [Abstract][Full Text] [Related]
15. Mechanism-based inactivation of cytochrome P450 3A4 by 17 alpha-ethynylestradiol: evidence for heme destruction and covalent binding to protein.
Lin HL; Kent UM; Hollenberg PF
J Pharmacol Exp Ther; 2002 Apr; 301(1):160-7. PubMed ID: 11907170
[TBL] [Abstract][Full Text] [Related]
16. Roles of divalent metal ions in oxidations catalyzed by recombinant cytochrome P450 3A4 and replacement of NADPH--cytochrome P450 reductase with other flavoproteins, ferredoxin, and oxygen surrogates.
Yamazaki H; Ueng YF; Shimada T; Guengerich FP
Biochemistry; 1995 Jul; 34(26):8380-9. PubMed ID: 7599128
[TBL] [Abstract][Full Text] [Related]
17. Molecular modeling of cytochrome P450 3A4.
Szklarz GD; Halpert JR
J Comput Aided Mol Des; 1997 May; 11(3):265-72. PubMed ID: 9263853
[TBL] [Abstract][Full Text] [Related]
18. Coexpression of genetically engineered fused enzyme between yeast NADPH-P450 reductase and human cytochrome P450 3A4 and human cytochrome b5 in yeast.
Hayashi K; Sakaki T; Kominami S; Inouye K; Yabusaki Y
Arch Biochem Biophys; 2000 Sep; 381(1):164-70. PubMed ID: 11019832
[TBL] [Abstract][Full Text] [Related]
19. Preparative use of isolated CYP102 monooxygenases -- a critical appraisal.
Eiben S; Kaysser L; Maurer S; Kühnel K; Urlacher VB; Schmid RD
J Biotechnol; 2006 Aug; 124(4):662-9. PubMed ID: 16716428
[TBL] [Abstract][Full Text] [Related]
20. Functional interactions in cytochrome P450BM3. Fatty acid substrate binding alters electron-transfer properties of the flavoprotein domain.
Murataliev MB; Feyereisen R
Biochemistry; 1996 Nov; 35(47):15029-37. PubMed ID: 8942669
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
